LEFO-Institute for Studies of the Medical Profession, Oslo, Norway
Nasjonalt folkehelseinstitutt, Oslo, Norway.
BMJ Open. 2019 Aug 30;9(8):e029739. doi: 10.1136/bmjopen-2019-029739.
Guidelines for cancer screening have been debated and are followed to varying degrees. We wanted to study whether and why doctors recommend disease-specific cancer screening to their patients.
Our cross-sectional survey used a postal questionnaire. The data were examined with descriptive methods and binary logistic regression.
We surveyed doctors working in all health services.
Our participants comprised a representative sample of Norwegian doctors in 2014/2015.
The primary outcome is whether doctors reported recommending their patients get screening for cancers of the breast, colorectum, lung, prostate, cervix and ovaries. We examined doctors' characteristics predicting adherence to the guidelines, including gender, age, and work in specialist or general practice. The secondary outcomes are reasons given for recommending or not recommending screening for breast and prostate cancer.
Our response rate was 75% (1158 of 1545). 94% recommended screening for cervical cancer, 89% for breast cancer (both established as national programmes), 42% for colorectal cancer (upcoming national programme), 41% for prostate cancer, 21% for ovarian cancer and 17% for lung cancer (not recommended by health authorities). General practitioners (GPs) adhered to guidelines more than other doctors. Early detection was the most frequent reason for recommending screening; false positives and needless intervention were the most frequent reasons for not recommending it.
A large majority of doctors claimed that they recommended cancer screening in accordance with national guidelines. Among doctors recommending screening contrary to the guidelines, GPs did so to a lesser degree than other specialties. Different expectations of doctors' roles could be a possible explanation for the variations in practice and justifications. The effectiveness of governing instruments, such as guidelines, incentives or reporting measures, can depend on which professional role(s) a doctor is loyal to, and policymakers should be aware of these different roles in clinical governance.
癌症筛查指南一直存在争议,并在不同程度上得到遵循。我们希望研究医生是否以及为何向患者推荐特定癌症的筛查。
我们的横断面调查使用了邮寄问卷。使用描述性方法和二项逻辑回归分析数据。
我们调查了所有卫生服务机构的医生。
我们的参与者包括 2014/2015 年挪威医生的代表性样本。
主要结果是医生是否报告建议其患者接受乳腺癌、结直肠癌、肺癌、前列腺癌、宫颈癌和卵巢癌的筛查。我们检查了医生特征预测对指南的依从性,包括性别、年龄以及在专科或全科实践中的工作。次要结果是推荐或不推荐筛查乳腺癌和前列腺癌的原因。
我们的回复率为 75%(1545 名中的 1158 名)。94%的医生建议进行宫颈癌筛查,89%的医生建议进行乳腺癌筛查(两者均为国家项目),42%的医生建议进行结直肠癌筛查(即将成为国家项目),41%的医生建议进行前列腺癌筛查,21%的医生建议进行卵巢癌筛查,17%的医生建议进行肺癌筛查(未被卫生当局推荐)。全科医生(GP)比其他医生更遵守指南。早期发现是推荐筛查的最常见原因;假阳性和不必要的干预是不推荐筛查的最常见原因。
绝大多数医生声称他们根据国家指南建议进行癌症筛查。在与指南建议相悖的筛查中,GP 的建议程度低于其他专科医生。医生角色的不同期望可能是实践和理由差异的一个可能解释。管理工具(如指南、激励措施或报告措施)的有效性可能取决于医生对哪个专业角色的忠诚,政策制定者应该意识到临床治理中的这些不同角色。